Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study

72Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims/hypothesis: Ceramides are sphingolipids that contribute to insulin resistance in preclinical studies. We hypothesised that plasma ceramides would be associated with body fat distribution, insulin resistance and incident type 2 diabetes in a multi-ethnic cohort. Methods: A total of 1557 participants in the Dallas Heart Study without type 2 diabetes underwent measurements of metabolic biomarkers, fat depots by MRI and plasma ceramides by liquid chromatography-mass spectrometry. Diabetes outcomes were assessed after 7 years. Associations of body fat and insulin resistance with ceramides at baseline and of ceramides with incident diabetes outcomes were analysed. Results: The cohort had a mean age of 43 years, with 58% women, 45% black participants and a mean BMI of 28 kg/m 2 . Total cholesterol levels were associated with all ceramides, but higher triacylglycerols and lower HDL-cholesterol and adiponectin were associated only with saturated fatty acid chain ceramides (p < 0.0003). After adjusting for clinical characteristics and total body fat, visceral adipose tissue was positively associated with saturated fatty acid ceramides (per SD, β = 0.16 to 0.18) and inversely associated with polyunsaturated fatty acid ceramides (β = −0.14 to −0.16, p < 0.001 for all). Lower-body subcutaneous fat showed an opposite pattern to that for visceral fat. HOMA-IR was positively associated with saturated (β = 0.08 to 0.09, p < 0.001) and inversely with polyunsaturated ceramides (β = −0.06 to −0.07, p < 0.05). Ceramides were not associated with incident type 2 diabetes after adjustment for clinical factors. Conclusions/interpretation: Plasma ceramides demonstrate a biologically complex relationship with metabolic and imaging indicators of dysfunctional adiposity. The role of ceramides in a shared pathway of metabolic dysfunction linking visceral adiposity and insulin resistance requires further investigation.

References Powered by Scopus

Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

28030Citations
N/AReaders
Get full text

Diagnosis and classification of diabetes mellitus

0
1815Citations
N/AReaders
Get full text

Mechanisms for insulin resistance: Common threads and missing links

1734Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

144Citations
N/AReaders
Get full text

Insulin signal transduction perturbations in insulin resistance

110Citations
N/AReaders
Get full text

Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism

108Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Neeland, I. J., Singh, S., McGuire, D. K., Vega, G. L., Roddy, T., Reilly, D. F., … Scherer, P. E. (2018). Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia, 61(12), 2570–2579. https://doi.org/10.1007/s00125-018-4720-1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 34

61%

Researcher 12

21%

Professor / Associate Prof. 6

11%

Lecturer / Post doc 4

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

43%

Biochemistry, Genetics and Molecular Bi... 16

35%

Pharmacology, Toxicology and Pharmaceut... 5

11%

Nursing and Health Professions 5

11%

Save time finding and organizing research with Mendeley

Sign up for free